Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
368 rows where has_known_aptamer = 0 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending
This data as json, CSV (advanced)
surface_class 1
- A2_pm_peripheral · 368 ✖
has_known_aptamer 1
- - · 368 ✖
has_activation_state_pdb_pair 1
- 0 368
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P35555 | FBN1 | Fibrillin-1 | Tier 1 | 0.809 | 1 | A2_pm_peripheral | 11 | 0 | 0 | 0 | 0 | 1 | Marfan syndrome | 0.8969300970597663 | ||||
| P51531 | SMARCA2 | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 | Tier 1 | 0.797 | 1 | A2_pm_peripheral | 31 | 65.06 | 0 | 0 | 0 | 0 | 1 | intellectual disability-sparse hair-brachydactyly syndrome | 0.85547142397368 | |||
| P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | Tier 1 | 0.794 | 1 | A2_pm_peripheral | 100 | 97.06 | 1 | 0 | 0 | 0 | 1 | intellectual disability, autosomal dominant 42 | 0.8462216225099116 | |||
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | Tier 1 | 0.794 | 1 | A2_pm_peripheral | 42 | 85.69 | 0 | 0 | 0 | 0 | 1 | T-B+ severe combined immunodeficiency due to JAK3 deficiency | 0.8450717197794638 | |||
| P29400 | COL4A5 | Collagen alpha-5(IV) chain | Tier 1.5 | 0.794 | 1 | A2_pm_peripheral | 2 | 48.12 | 0 | 0 | 0 | 0 | 1 | X-linked Alport syndrome | 0.8472963899466404 | |||
| Q14315 | FLNC | Filamin-C | Tier 1.5 | 0.791 | 1 | A2_pm_peripheral | 14 | 75.06 | 0 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy 26 | 0.8363192336142512 | |||
| O75369 | FLNB | Filamin-B | Tier 1 | 0.788 | 1 | A2_pm_peripheral | 23 | 76.25 | 0 | 0 | 0 | 0 | 1 | Larsen syndrome | 0.826975893141549 | |||
| P06737 | PYGL | Glycogen phosphorylase, liver form | Tier 1 | 0.787 | 1 | A2_pm_peripheral | 19 | 92.69 | 1 | 0 | 0 | 0 | 1 | glycogen storage disease VI | 0.8220063508118274 | |||
| P49770 | EIF2B2 | Translation initiation factor eIF2B subunit beta | Tier 1 | 0.787 | 1 | A2_pm_peripheral | 25 | 86.56 | 1 | 0 | 0 | 0 | 1 | CACH syndrome | 0.824634396744653 | |||
| P21333 | FLNA | Filamin-A | Tier 1 | 0.786 | 1 | A2_pm_peripheral | 26 | 76.56 | 1 | 0 | 0 | 0 | 1 | Melnick-Needles syndrome | 0.8200516896124751 | |||
| P31040 | SDHA | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Tier 1.5 | 0.785 | 1 | A2_pm_peripheral | 4 | 93.94 | 1 | 0 | 0 | 0 | 1 | mitochondrial complex II deficiency, nuclear type 1 | 0.815589203208636 | |||
| O43175 | PHGDH | D-3-phosphoglycerate dehydrogenase | Tier 1 | 0.784 | 1 | A2_pm_peripheral | 21 | 92.94 | 0 | 0 | 0 | 0 | 1 | PHGDH deficiency | 0.8128323162948055 | |||
| Q9Y3Z3 | SAMHD1 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Tier 1 | 0.783 | 1 | A2_pm_peripheral | 76 | 88.19 | 0 | 0 | 0 | 0 | 1 | Aicardi-Goutières syndrome | 0.8101030032946703 | |||
| Q8TD16 | BICD2 | Protein bicaudal D homolog 2 | Tier 1 | 0.782 | 1 | A2_pm_peripheral | 2 | 78.0 | 0 | 0 | 0 | 0 | 1 | autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures | 0.8072433385790271 | |||
| Q08499 | PDE4D | 3',5'-cyclic-AMP phosphodiesterase 4D | Tier 1 | 0.782 | 1 | A2_pm_peripheral | 100 | 67.44 | 0 | 0 | 0 | 0 | 1 | acrodysostosis 2 with or without hormone resistance | 0.8053064772512085 | |||
| Q01831 | XPC | DNA repair protein complementing XP-C cells | Tier 1 | 0.782 | 1 | A2_pm_peripheral | 14 | 66.56 | 1 | 0 | 0 | 0 | 1 | Xeroderma pigmentosum complementation group C | 0.8056391472748724 | |||
| O95630 | STAMBP | STAM-binding protein | Tier 1.5 | 0.782 | 1 | A2_pm_peripheral | 5 | 84.0 | 0 | 0 | 0 | 0 | 1 | microcephaly-capillary malformation syndrome | 0.8060251236043802 | |||
| Q96BN8 | OTULIN | Ubiquitin thioesterase otulin | Tier 1 | 0.781 | 1 | A2_pm_peripheral | 12 | 83.81 | 0 | 0 | 0 | 0 | 1 | autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive | 0.804614072482804 | |||
| Q12840 | KIF5A | Kinesin heavy chain isoform 5A | Tier 1.5 | 0.781 | 1 | A2_pm_peripheral | 4 | 75.31 | 1 | 0 | 0 | 0 | 1 | hereditary spastic paraplegia 10 | 0.8029405627392309 | |||
| O00330 | PDHX | Pyruvate dehydrogenase protein X component, mitochondrial | Tier 1.5 | 0.779 | 1 | A2_pm_peripheral | 5 | 77.31 | 1 | 0 | 0 | 0 | 1 | pyruvate dehydrogenase E3-binding protein deficiency | 0.7957753555992844 | |||
| Q9NQG7 | HPS4 | BLOC-3 complex member HPS4 | Tier 1.5 | 0.779 | 1 | A2_pm_peripheral | 1 | 61.66 | 1 | 0 | 0 | 0 | 1 | Hermansky-Pudlak syndrome with pulmonary fibrosis | 0.7967575753847002 | |||
| P49773 | HINT1 | Adenosine 5'-monophosphoramidase HINT1 | Tier 1 | 0.777 | 1 | A2_pm_peripheral | 59 | 96.19 | 0 | 0 | 0 | 0 | 1 | Autosomal recessive axonal neuropathy with neuromyotonia | 0.7895184274923306 | |||
| P12814 | ACTN1 | Alpha-actinin-1 | Tier 1.5 | 0.777 | 1 | A2_pm_peripheral | 4 | 85.25 | 0 | 0 | 0 | 0 | 1 | platelet-type bleeding disorder 15 | 0.7887662502912471 | |||
| O00468 | AGRN | Agrin | Tier 1.5 | 0.777 | 1 | A2_pm_peripheral | 1 | 68.81 | 1 | 0 | 0 | 0 | 1 | congenital myasthenic syndrome 8 | 0.7912009864338403 | |||
| Q9Y263 | PLAA | Phospholipase A-2-activating protein | Tier 1 | 0.77 | 1 | A2_pm_peripheral | 5 | 84.0 | 0 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | 0.7656265019633831 | |||
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | Tier 1 | 0.768 | 1 | A2_pm_peripheral | 96 | 83.94 | 0 | 0 | 0 | 0 | 1 | immunodeficiency 67 | 0.7593923638641371 | |||
| Q9BYI3 | HYCC1 | Hyccin | Tier 1 | 0.766 | 1 | A2_pm_peripheral | 5 | 67.75 | 1 | 0 | 0 | 0 | 1 | Hypomyelination - congenital cataract | 0.7528702184568328 | |||
| Q9NZ09 | UBAP1 | Ubiquitin-associated protein 1 | Tier 1.5 | 0.764 | 1 | A2_pm_peripheral | 3 | 62.5 | 0 | 0 | 0 | 0 | 1 | spastic paraplegia 80, autosomal dominant | 0.7464670113492812 | |||
| Q01484 | ANK2 | Ankyrin-2 | Tier 1 | 0.762 | 1 | A2_pm_peripheral | 11 | 61.78 | 0 | 0 | 0 | 0 | 1 | Romano-Ward syndrome | 0.7390647393986454 | |||
| Q6NZI2 | CAVIN1 | Caveolae-associated protein 1 | Tier 1.5 | 0.76 | 1 | A2_pm_peripheral | 3 | 67.38 | 0 | 0 | 0 | 0 | 1 | congenital generalized lipodystrophy type 4 | 0.7317728549444928 | |||
| Q92997 | DVL3 | Segment polarity protein dishevelled homolog DVL-3 | Tier 1.5 | 0.759 | 1 | A2_pm_peripheral | 9 | 58.91 | 0 | 0 | 0 | 0 | 1 | autosomal dominant Robinow syndrome | 0.7284158836126389 | |||
| P13797 | PLS3 | Plastin-3 | Tier 1 | 0.757 | 1 | A2_pm_peripheral | 6 | 88.75 | 1 | 0 | 0 | 0 | 1 | X-linked osteoporosis with fractures | 0.721756781312783 | |||
| P07948 | LYN | Tyrosine-protein kinase Lyn | Tier 1 | 0.754 | 1 | A2_pm_peripheral | 6 | 83.12 | 0 | 0 | 0 | 0 | 1 | autoinflammatory disease, systemic, with vasculitis | 0.7119500711989845 | |||
| P22735 | TGM1 | Protein-glutamine gamma-glutamyltransferase K | Tier 1.5 | 0.754 | 1 | A2_pm_peripheral | 1 | 84.12 | 0 | 0 | 0 | 0 | 1 | autosomal recessive congenital ichthyosis | 0.714755023666953 | |||
| P31939 | ATIC | Bifunctional purine biosynthesis protein ATIC | Tier 1.5 | 0.754 | 1 | A2_pm_peripheral | 5 | 97.38 | 0 | 0 | 0 | 0 | 1 | AICA-ribosiduria | 0.7137167364484167 | |||
| O15117 | FYB1 | FYN-binding protein 1 | Tier 1 | 0.752 | 1 | A2_pm_peripheral | 3 | 56.59 | 0 | 0 | 0 | 0 | 1 | thrombocytopenia 3 | 0.7067701415491194 | |||
| P07357 | C8A | Complement component C8 alpha chain | Tier 1 | 0.75 | 1 | A2_pm_peripheral | 11 | 78.69 | 1 | 0 | 0 | 0 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.700643416115894 | |||
| Q9Y5K6 | CD2AP | CD2-associated protein | Tier 1 | 0.749 | 1 | A2_pm_peripheral | 12 | 62.22 | 0 | 0 | 0 | 0 | 1 | focal segmental glomerulosclerosis | 0.6952333377860125 | |||
| Q8IZQ1 | WDFY3 | WD repeat and FYVE domain-containing protein 3 | Tier 1 | 0.748 | 1 | A2_pm_peripheral | 2 | 0 | 0 | 0 | 0 | 1 | Autosomal dominant microcephaly | 0.6934322596452817 | ||||
| Q8IXK2 | GALNT12 | Polypeptide N-acetylgalactosaminyltransferase 12 | Tier 1.5 | 0.748 | 1 | A2_pm_peripheral | 1 | 93.5 | 0 | 0 | 0 | 0 | 1 | colorectal cancer, susceptibility to, 1 | 0.6932727729787528 | |||
| Q96CW1 | AP2M1 | AP-2 complex subunit mu | Tier 1 | 0.741 | 1 | A2_pm_peripheral | 4 | 89.19 | 0 | 0 | 0 | 0 | 1 | intellectual developmental disorder 60 with seizures | 0.6712897942723018 | |||
| O43516 | WIPF1 | WAS/WASL-interacting protein family member 1 | Tier 1.5 | 0.737 | 1 | A2_pm_peripheral | 4 | 58.5 | 0 | 0 | 0 | 0 | 1 | Wiskott-Aldrich syndrome | 0.6561328889736038 | |||
| P48730 | CSNK1D | Casein kinase I isoform delta | Tier 1 | 0.732 | 1 | A2_pm_peripheral | 46 | 81.0 | 0 | 0 | 0 | 0 | 1 | Familial advanced sleep-phase syndrome | 0.6394614732145313 | |||
| P27815 | PDE4A | 3',5'-cyclic-AMP phosphodiesterase 4A | Tier 1 | 0.732 | 1 | A2_pm_peripheral | 5 | 64.5 | 0 | 0 | 0 | 0 | 1 | psoriasis | 0.6394621747004946 | |||
| Q12929 | EPS8 | Epidermal growth factor receptor kinase substrate 8 | Tier 1.5 | 0.731 | 1 | A2_pm_peripheral | 2 | 70.31 | 0 | 0 | 0 | 0 | 1 | autosomal recessive nonsyndromic hearing loss 102 | 0.6354471967036509 | |||
| Q5VST9 | OBSCN | Obscurin | Tier 1 | 0.73 | 1 | A2_pm_peripheral | 25 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.6328288822708418 | ||||
| Q9NZ56 | FMN2 | Formin-2 | Tier 1.5 | 0.729 | 1 | A2_pm_peripheral | 2 | 49.97 | 0 | 0 | 0 | 0 | 1 | autosomal recessive non-syndromic intellectual disability | 0.6298956049368037 | |||
| P11233 | RALA | Ras-related protein Ral-A | Tier 1 | 0.723 | 1 | A2_pm_peripheral | 16 | 89.31 | 0 | 0 | 0 | 0 | 1 | Hiatt-Neu-Cooper neurodevelopmental syndrome | 0.6092132376035464 | |||
| Q16186 | ADRM1 | Proteasomal ubiquitin receptor ADRM1 | Tier 1 | 0.722 | 1 | A2_pm_peripheral | 21 | 62.28 | 0 | 0 | 0 | 0 | 1 | multiple myeloma | 0.6073517074927846 | |||
| Q96RT1 | ERBIN | Erbin | Tier 1 | 0.719 | 1 | A2_pm_peripheral | 11 | 55.66 | 0 | 0 | 0 | 0 | 1 | cancer | 0.5976773185991211 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;